mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.04 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |